The Lung Cancer Surgery Market is expected to reach US$8.76 billion by 2031, registering a CAGR of 5.1% during 2025–2031. The market is supported by the increasing burden of lung cancer, growing adoption of minimally invasive surgical techniques, improvements in surgical instruments, and advancements in robotic-assisted procedures. Rising investments in cancer...